The bidding and procurement of drugs is an important content and key link in deepening the reform of the medical and health system. How to reduce drug prices while ensuring drug supply, to solve the problem of clinical drug shortage? China this year to promote the "drug reform", to improve the centralized procurement of drugs, and strive to establish a cheap "life-saving drugs" supply guarantee mechanism.
Actinomycin D is a chemotherapy drug mainly used to treat common malignant solid tumors such as nephroblastoma in children. In some solid tumor diagnosis and treatment guidelines issued by the World Health Organization, actinomycin D is listed as the preferred chemotherapy regimen. Such a clinical urgently needed tumor chemotherapy drug, each only tens of yuan, is a veritable cheap "life-saving medicine."
However, in recent years, actinomycin D is frequently out of stock, and many patients with urgent treatment have no drugs available, or are forced to choose a foreign alternative medicine of nearly 6,000 yuan.
On September 21, 2015, Hisun Pfizer announced the launch of actinomycin D from a new production line. This cheap "life-saving drug" has finally returned to the market in anticipation of cancer patients.
The new batch of actinomycin D was produced first by all Hisun Pfizer employees against the pressure of huge cost increases and profit losses of single drug." Du Jiaqiu, vice president of Pfizer, said that a number of "life-saving drugs" with small overall dosage, narrow indications and irreplaceable efficacy, including actinomycin D, are facing an embarrassing situation of shortage. The responsibility for ensuring access to such medicines must be shared between governments, businesses and society.
"After all, it is not a long-term solution for enterprises to \'make money at a loss\'. We look forward to further improving the mechanism for ensuring the supply of medicines in Documents 7 and 70." \'said Dugaccio.
The No. 7 document Du Jiaqiu said is the guiding opinions on improving the centralized drug procurement work of public hospitals issued by The State Council this year, and the No. 70 document is the Notice of the National Health and Family Planning Commission on Implementing the Guiding Opinions on Improving the centralized drug Procurement work of Public Hospitals.
In the process of the new medical reform, the Chinese government has built a new mechanism of centralized drug procurement with the essential drug system as the core. According to the "China Medical Reform Development Report (2009-2014)" released by the Chinese Academy of Medical Sciences, the new mechanism of centralized drug procurement has established a institutional framework of centralized drug procurement under which the government formulates the bidding and procurement methods for essential drugs and local governments lead the procurement and distribution of essential drugs, which has prompted changes in the procurement model. To promote the changes in the production, circulation, use and management of drugs in China will have a positive impact on improving the efficiency of drug supply and standardized management level. At the same time, taking the implementation of the basic drug system as an opportunity to promote the comprehensive reform of the grass-roots health system, and have a positive impact on the medication behavior of medical and health institutions and patients.
However, in the process of centralized drug procurement, there is also a disconnect between drug bidding and procurement in some hospitals, and the prices of some drugs are not high, while the prices of other drugs are "low" or even disappear.
In response to these problems, China has issued a series of documents this year, requiring a new round of drug procurement to be fully launched within the year.
"Documents 7 and 70 are new mechanisms for the classified procurement of drugs, and ensuring the supply of drugs is one of the basic requirements." Han Huixue, director of the Drug supply Management Division of the Pharmaceutical Administration Department of the National Health and Family Planning Commission, said, "In the direct network procurement, enterprises can report a price higher than the previous bid price and the maximum price of the Development and Reform Commission, and form drug prices through negotiations with hospitals." I hope the provincial bidding platforms can do a good job in supervision and service."
Around the key links of "what to recruit, how to recruit, how to distribute, how to settle, how to supervise", The State Council\'s guiding opinions on improving the centralized procurement of drugs in public hospitals put forward a series of measures: First, the implementation of classified procurement of drugs. For different drugs, bidding procurement, negotiation procurement, direct hospital procurement, fixed-point production and other methods are adopted to ensure drug supply and reduce inflated prices. The second is to improve the settlement method of drug money. Encourage drug manufacturers and hospitals to settle drug payments directly, and settle distribution costs with distribution enterprises to further reduce intermediate links. Third, strengthen the management of drug distribution. Focus on ensuring drug supply and distribution in remote and inaccessible areas, and encourage all localities to explore integrated county and rural distribution in light of actual conditions. The fourth is to standardize the construction of procurement platforms. Expand the functions of the provincial centralized drug procurement platform, unify the drug procurement code, disclose drug procurement information, and realize drug procurement data sharing and interconnection. Fifth, we will strengthen comprehensive oversight and management. Hospitals and drug production and trading enterprises will be investigated and punished for violations of laws and regulations.
This new mechanism embodies the combination of unification and division, and the combination of decentralization and regulation. Especially in the direct online procurement method, on the basis of the direct online procurement of commonly used low-cost drugs, the scope of use of drugs has been further expanded, including women and children specialty generic drugs, emergency drugs, basic infusion, and so on." According to Han Hui, this will help ensure the supply of drugs, meet the needs of patients, and find cheap "life-saving drugs" that have disappeared.
Information Source: Xinhuanet